Sinnott v. Aqua-Chem, Inc., 88062 (7-31-2008)

2008 Ohio 3806
CourtOhio Court of Appeals
DecidedJuly 31, 2008
DocketNo. 88062.
StatusUnpublished
Cited by4 cases

This text of 2008 Ohio 3806 (Sinnott v. Aqua-Chem, Inc., 88062 (7-31-2008)) is published on Counsel Stack Legal Research, covering Ohio Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sinnott v. Aqua-Chem, Inc., 88062 (7-31-2008), 2008 Ohio 3806 (Ohio Ct. App. 2008).

Opinion

JOURNAL ENTRY AND OPINION *Page 4
{¶ 1} Defendants-appellants appeal the decision of the lower court. Having reviewed the arguments of the parties and the pertinent law, we hereby affirm the lower court.

I.
{¶ 2} According to the facts and the case, appellees James ("James") and Freda Sinnott (collectively "appellees") filed their initial complaint on February 10, 2004. The complaint was filed before the enactment of Am. Sub. H.B. No. 292, 150 Ohio Laws, Part III, 3970 ("H.B. No. 292"), 1 which included new requirements for the filing of asbestos complaints pursuant to R.C. 2307.92. Appellees2 filed their complaint against several companies, including the following: American Optical Corporation, Abex Corporation, now known as Pneumo Abex LLC, and Viacom, Inc., Aqua-Chem Inc., and others, alleging injury to James Sinnott from workplace exposure to products containing asbestos.

{¶ 3} In April 2004, appellees dismissed without prejudice American Optical Corporation and Pneumo Abex. After the effective date of H.B. No. 292, in January 2005, appellees filed an amended complaint, again naming appellants American Optical Corporation and Pneumo Abex as defendants. *Page 5

{¶ 4} Because the amended complaint was filed after the effective date of H.B. No. 292, American Optical Corporation filed a motion to administratively dismiss appellees' claim for failure to comply with R.C. 2307.92. Pneumo Abex later joined that motion. Although appellees opposed the motion to dismiss, they also provided supplemental medical evidence and records regarding James' illness. American Optical Corporation continued to argue for administrative dismissal, claiming that the supplemental evidence did not satisfy the requirements of R.C. 2307.91, et seq. The trial court held that while the requirements of H.B. No. 292 applied to the amended complaint, appellees had fulfilled those requirements, and the case could proceed to trial.

{¶ 5} Appellants filed an appeal with this court that was dismissed as premature pursuant to R.C. 2505.02.3 Appellants then filed an appeal with the Ohio Supreme Court, who reversed and remanded the case on October 25, 2007. The Ohio Supreme Court determined that orders finding that plaintiffs have made the prima facie showings required by R.C. 2307.92 are final and appealable. This case is now again before this court of appeals.

II.
{¶ 6} Appellants' assignment of error provides the following: "The trial court erred in finding that Plaintiff made a prima-facie showing under R.C. 2307.92."

III. *Page 6
{¶ 7} Appellants argue in their sole assignment of error that the lower court erred in finding that plaintiff made a prima-facie showing under R.C. 2307.92.

{¶ 8} An order finding that a plaintiff in an asbestos action has made the prima facie showing required by R.C. 2307.92 is a final, appealable order under R.C. 2505.02(B)(4). Sinnott v. Aqua-Chem, Inc.,116 Ohio St.3d 158, 2007-Ohio-5584, 876 N.E.2d 1217.

{¶ 9} Prior to the enactment of H.B. No. 292, the prior statute, R.C. 2305.10, set forth the prevailing requirements placed upon an asbestos litigant:

{¶ 10} "a cause of action for bodily injury caused by exposure toasbestos * * * arises upon the date on which the Plaintiff-Appellee isinformed by competent medical authority that the Plaintiff-Appellee hasbeen injured by such exposure, or upon the date on which, by exercise ofreasonable diligence, the Plaintiff-Appellee should have become awarethat he had been injured by the exposure, whichever date occursfirst."4

{¶ 11} H.B. No. 292, the asbestos litigation bill, became effective on September 2, 2004. The General Assembly found it crucial to codify these criteria because the "vast majority" of asbestos claims "are filed by individuals who allege they have been exposed to asbestos and who have some physical sign of exposure to asbestos, but who do not suffer from an asbestos-related impairment."5 *Page 7

{¶ 12} The statutory mandate to satisfy certain minimum "prima-facie" criteria is set forth at R.C. 2307.93(A). This statute provides:

"The plaintiff in any tort action who alleges an asbestos claim shall file * * * a written report and supporting test results constituting prima-facie evidence of the exposed person's physical impairment that meets the minimum requirements specified in division (B), (C), or (D) of section 2307.92 of the Revised Code, whichever is applicable."6

{¶ 13} Divisions (B), (C), and (D) of R.C. 2307.92 describe the minimum requirements for three different classes of asbestos claims: a claim based on a nonmalignant condition (Division B); a claim based upon lung cancer of an exposed person who is a smoker (Division C); and a claim based upon a wrongful death (Division D).7

{¶ 14} The requirements for all three divisions involve a "competent medical authority" who indicates to the court that the plaintiff has satisfied a minimum medical threshold sufficient to support that the "person's exposure to asbestos is a substantial contributing factor to the medical condition."8 "Competent medical authority," for purposes of the prima-facie showing is, among other things, a treating physician who actually has or had a doctor-patient relationship with the exposed person. See R.C. 2307.91(Z).

{¶ 15} In the case at bar, James was diagnosed with a lung mass that was observed on an x-ray in August 2003 after completing a series of tests. The tests included pulmonary function tests and x-rays by certified pulmonologist and B-Reader, Robert Altmeyer, M.D. *Page 8 Dr. Altmeyer discussed the matter with James and recommended further testing. Subsequent tests and a lung biopsy at the Veterans Administration Hospital in Huntington, West Virginia confirmed the malignancy.

{¶ 16} Later, a Dr. Ross referred James to a pulmonary specialist, Dr. Ammar Ghanem; also signing was Dr. Nancy Munn. Throughout the records are notations documenting James' history.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cook v. NL Industries, Inc.
2013 Ohio 5119 (Ohio Court of Appeals, 2013)
Renfrow v. Norfolk S. Ry. Co.
2013 Ohio 1189 (Ohio Court of Appeals, 2013)
Paul v. Consol. Rail Corp.
2013 Ohio 1038 (Ohio Court of Appeals, 2013)
Whipkey v. Aqua-Chem, Inc.
2012 Ohio 918 (Ohio Court of Appeals, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
2008 Ohio 3806, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sinnott-v-aqua-chem-inc-88062-7-31-2008-ohioctapp-2008.